A director just bought 300,000 shares, or $435,000 worth of stock, at $1.45 per share.

From a technical perspective, PRTS is currently trending below both its 50-day and 200-day moving averages, which is bearish. This stock has been downtrending badly for the last three months, with shares dropping from its high of $2.24 to its recent low of $1 a share. During that move, shares of PRTS have been consistently making lower highs and lower lows, which is bearish technical price action. That said, shares of PRTS have started to bounce off that $1 low and are starting to move within range of triggering a near-term breakout trade.

If you're in the bull camp on PRTS, then look for long-biased as long as this stock is trending above $1.10 and then once it breaks out above some near-term overhead resistance levels at $1.17 to $1.28 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 63,216 shares. If that breakout triggers, then PRTS will set up to re-test or possibly take out its next major overhead resistance levels at its 50-day moving average of $1.44 to around $1.60 a share. Any high-volume move above $1.60 will then put $1.80 to $2 into range for shares of PRTS.


An aerospace and defense stock that insiders are active in here is AeroVironment ( AVAV), which is engaged in the design, development, production and support of unmanned aircraft systems and efficient energy systems for various industries and governmental agencies. Insiders are buying this stock into notable weakness, since shares are off by 23% during the last six months.

AeroVironment has a market cap of $409 million and an enterprise value of $267 million. This stock trades at a premium valuation, with a trailing price-to-earnings of 14.37 and a forward price-to-earnings of 37.02. Its estimated growth rate for this year is -69%, and for next year it's pegged at 22%. This is a cash-rich company, since the total cash position on its balance sheet is $133.79 million and its total debt is zero.

If you liked this article you might like

NovoCure, NextEra, O'Reilly: 'Mad Money' Lightning Round (7/7/17)

What to Watch During the Week: Cramer's 'Mad Money' Recap (Friday 7/7/17)

These Stocks Are Trending Up With Monster Volume

7 Stocks Trending Up With Monster Volume